Literature DB >> 20521044

Radionuclide imaging of perfusion and hypoxia.

George Laking1, Pat Price.   

Abstract

PURPOSE: We present a review of radionuclide imaging of tumour vascular physiology as it relates to angiogenesis. We focus on clinical trials in human subjects using PET and SPECT to evaluate tumour physiology, in particular blood flow and hypoxia.
METHODS: A systematic review of literature based on MEDLINE searches updated in February 2010 was performed.
RESULTS: Twenty-nine studies were identified for review: 14 dealt with (15)O-water PET perfusion imaging, while 8 dealt with (18)F-fluoromisonidazole PET hypoxia imaging. Five used SPECT methods. The studies varied widely in technical quality and reporting of methods.
CONCLUSIONS: A subset of radionuclide methods offers accurate quantitative scientific observations on tumour vascular physiology of relevance to angiogenesis and its treatment. The relationship between cellular processes of angiogenesis and changing physiological function remains poorly defined. The promise of quantitative functional imaging at high specificity and low administered dose sustains interest in radionuclide methods.

Entities:  

Mesh:

Year:  2010        PMID: 20521044     DOI: 10.1007/s00259-010-1453-x

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  52 in total

Review 1.  Consensus nomenclature for in vivo imaging of reversibly binding radioligands.

Authors:  Robert B Innis; Vincent J Cunningham; Jacques Delforge; Masahiro Fujita; Albert Gjedde; Roger N Gunn; James Holden; Sylvain Houle; Sung-Cheng Huang; Masanori Ichise; Hidehiro Iida; Hiroshi Ito; Yuichi Kimura; Robert A Koeppe; Gitte M Knudsen; Juhani Knuuti; Adriaan A Lammertsma; Marc Laruelle; Jean Logan; Ralph Paul Maguire; Mark A Mintun; Evan D Morris; Ramin Parsey; Julie C Price; Mark Slifstein; Vesna Sossi; Tetsuya Suhara; John R Votaw; Dean F Wong; Richard E Carson
Journal:  J Cereb Blood Flow Metab       Date:  2007-05-09       Impact factor: 6.200

2.  Quantifying tumour hypoxia with fluorine-18 fluoroerythronitroimidazole ([18F]FETNIM) and PET using the tumour to plasma ratio.

Authors:  Kaisa Lehtiö; Vesa Oikonen; Samuel Nyman; Tove Grönroos; Anne Roivainen; Olli Eskola; Heikki Minn
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-10-30       Impact factor: 9.236

3.  Phase I trial of concurrent tirapazamine, cisplatin, and radiotherapy in patients with advanced head and neck cancer.

Authors:  D Rischin; L Peters; R Hicks; P Hughes; R Fisher; R Hart; M Sexton; I D'Costa; R von Roemeling
Journal:  J Clin Oncol       Date:  2001-01-15       Impact factor: 44.544

4.  Openings between defective endothelial cells explain tumor vessel leakiness.

Authors:  H Hashizume; P Baluk; S Morikawa; J W McLean; G Thurston; S Roberge; R K Jain; D M McDonald
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

5.  Blood flow and metabolism in locally advanced breast cancer: relationship to response to therapy.

Authors:  David A Mankoff; Lisa K Dunnwald; Julie R Gralow; Georgiana K Ellis; Aaron Charlop; Thomas J Lawton; Erin K Schubert; Jeffrey Tseng; Robert B Livingston
Journal:  J Nucl Med       Date:  2002-04       Impact factor: 10.057

6.  Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy.

Authors:  Susanne-Martina Eschmann; Frank Paulsen; Matthias Reimold; Helmut Dittmann; Stefan Welz; Gerald Reischl; Hans-Juergen Machulla; Roland Bares
Journal:  J Nucl Med       Date:  2005-02       Impact factor: 10.057

7.  Measurements of blood flow and exchanging water space in breast tumors using positron emission tomography: a rapid and noninvasive dynamic method.

Authors:  C B Wilson; A A Lammertsma; C G McKenzie; K Sikora; T Jones
Journal:  Cancer Res       Date:  1992-03-15       Impact factor: 12.701

Review 8.  Molecular imaging of hypoxia with radiolabelled agents.

Authors:  Gilles Mees; Rudi Dierckx; Christel Vangestel; Christophe Van de Wiele
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-06-30       Impact factor: 9.236

9.  Tumor blood flow measured by perfusion computed tomography and 15O-labeled water positron emission tomography: a comparison study.

Authors:  Chaan S Ng; Yoshihisa Kodama; Nizar A Mullani; Bruce J Barron; Wei Wei; Roy S Herbst; James L Abbruzzese; Chusilp Charnsangavej
Journal:  J Comput Assist Tomogr       Date:  2009 May-Jun       Impact factor: 1.826

10.  Identification of angiogenesis in primary breast carcinoma according to the image analysis.

Authors:  Sung-Won Kim; Sung-Shin Park; Soo-Jung Ahn; Ki-Wook Chung; Woo Kyung Moon; Jung-Gi Im; Jeong Seok Yeo; June-Key Chung; Dong-Young Noh
Journal:  Breast Cancer Res Treat       Date:  2002-07       Impact factor: 4.872

View more
  8 in total

1.  Imaging of angiogenesis: from morphology to molecules and from bench to bedside.

Authors:  Ambros J Beer; Xiaoyuan Chen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-08       Impact factor: 9.236

2.  Biological correlates of tumor perfusion and its heterogeneity in newly diagnosed breast cancer using dynamic first-pass 18F-FDG PET/CT.

Authors:  Neree Payan; Benoit Presles; François Brunotte; Charles Coutant; Isabelle Desmoulins; Jean-Marc Vrigneaud; Alexandre Cochet
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-08-08       Impact factor: 9.236

Review 3.  Radionuclide imaging and therapy directed towards the tumor microenvironment: a multi-cancer approach for personalized medicine.

Authors:  Circe D van der Heide; Simone U Dalm
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-07-05       Impact factor: 9.236

Review 4.  Positron emission tomography to assess hypoxia and perfusion in lung cancer.

Authors:  Eline E Verwer; Ronald Boellaard; Astrid Am van der Veldt
Journal:  World J Clin Oncol       Date:  2014-12-10

5.  Modeling of nanotherapeutics delivery based on tumor perfusion.

Authors:  Anne L van de Ven; Behnaz Abdollahi; Carlos J Martinez; Lacey A Burey; Melissa D Landis; Jenny C Chang; Mauro Ferrari; Hermann B Frieboes
Journal:  New J Phys       Date:  2013-05-08       Impact factor: 3.729

6.  PET Tracers for Clinical Imaging of Breast Cancer.

Authors:  Iván Peñuelas; Inés Domínguez-Prado; María J García-Velloso; Josep M Martí-Climent; Macarena Rodríguez-Fraile; Carlos Caicedo; María Sánchez-Martínez; José A Richter
Journal:  J Oncol       Date:  2012-08-29       Impact factor: 4.375

7.  Hypoxia, blood flow and metabolism in squamous-cell carcinoma of the head and neck: correlations between multiple immunohistochemical parameters and PET.

Authors:  Tove J Grönroos; Kaisa Lehtiö; Karl-Ove Söderström; Pauliina Kronqvist; Jukka Laine; Olli Eskola; Tapio Viljanen; Reidar Grénman; Olof Solin; Heikki Minn
Journal:  BMC Cancer       Date:  2014-11-24       Impact factor: 4.430

8.  Non-conventional and Investigational PET Radiotracers for Breast Cancer: A Systematic Review.

Authors:  Michele Balma; Virginia Liberini; Manuela Racca; Riccardo Laudicella; Matteo Bauckneht; Ambra Buschiazzo; Daniele Giovanni Nicolotti; Simona Peano; Andrea Bianchi; Giovanni Albano; Natale Quartuccio; Ronan Abgral; Silvia Daniela Morbelli; Calogero D'Alessandria; Enzo Terreno; Martin William Huellner; Alberto Papaleo; Désirée Deandreis
Journal:  Front Med (Lausanne)       Date:  2022-04-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.